Exocrine Pancreatic Insufficiency (EPI) is a condition where the pancreas does not produce enough digestive enzymes. This can lead to significant digestive issues and nutrient malabsorption in dogs and cats. Fortunately, with the right management strategies, most affected pets can live comfortable lives. The primary treatment involves Pancreatic Enzyme Replacement Therapy (PERT), often supplemented with cobalamin and dietary adjustments. Understanding these key aspects is crucial for owners of pets diagnosed with EPI.
Pancreatic Enzyme Replacement Therapy (PERT)
The cornerstone of managing EPI is PERT, which involves supplementing the pet’s diet with the digestive enzymes their pancreas cannot produce. Various enzyme formulations are available, with powders generally being more effective than tablets, capsules, or enteric-coated products. For dogs, the recommended initial dose is 1 teaspoon of powder per 10 kg of body weight, mixed with each meal. Cats typically require 1 teaspoon per cat, also mixed with each meal.
An alternative to commercial enzyme powders is fresh pancreatic tissue. Approximately 30–90 grams of raw, chopped pancreas can substitute for one teaspoon of pancreatic extract. Raw pancreas can be frozen for several months without losing its enzymatic activity, making it a practical option for some owners. Pre-incubation of food with enzymes or adding bile salts is not necessary for successful treatment.
Once clinical signs have resolved, the enzyme dose can be gradually reduced to the lowest effective level. It’s important to note that enzyme efficacy can vary between batches. Some studies have reported oral bleeding in a small number of dogs treated with pancreatic enzyme supplements; this usually resolves by decreasing the enzyme dose. Moistening the food and enzyme mixture may also help mitigate this adverse effect. While PERT significantly improves clinical signs, it may not fully normalize nutrient absorption, particularly of fats. Therefore, feeding low-fat diets is generally not recommended as it can lead to deficiencies in fat-soluble vitamins and essential fatty acids.
Dietary Considerations for EPI Pets
Dietary modifications play a supportive role in managing EPI. Some types of dietary fiber can interfere with pancreatic enzyme activity. For this reason, a diet low in insoluble or nonfermentable fiber is recommended. Conversely, fermentable fibers, such as fructooligosaccharides or beet pulp, can be safely included in the diet. These fibers can potentially support a healthier gut environment.
Cobalamin Supplementation
Cobalamin (Vitamin B12) deficiency is a common concurrent issue in animals with EPI, contributing to persistent clinical signs even with enzyme supplementation. If a severely decreased serum cobalamin concentration is detected, supplementation is necessary. This can be administered parenterally (by injection) or orally. For dogs, parenteral dosage is typically 25 mcg/kg weekly, while oral dosage is 25 mcg/kg daily. For cats, parenteral dosage is 250 mcg per cat weekly, and oral dosage is 250 mcg per cat daily.
Addressing Concurrent Small Intestinal Disease
Some animals with EPI may not fully respond to enzyme supplementation and cobalamin therapy, suggesting the presence of concurrent small intestinal disease. Small intestinal dysbiosis is common in these patients and may benefit from antimicrobial therapy, such as tylosin, or fecal microbiota transplantation (FMT). Chronic inflammatory enteropathy, also known as inflammatory bowel disease, can also occur in some animals with EPI.
In rare cases where pets do not respond to standard PERT, antacid therapy might be considered. While generally unnecessary, administering a proton pump inhibitor like omeprazole (0.7–1.0 mg/kg every 12 hours) could potentially prevent the inactivation of pancreatic enzymes as they pass through the stomach to the small intestine.